▶ 調査レポート

世界のマイクロ流体イムノアッセイ システム市場(~2028年):マイクロ流体解析装置、マイクロ流体カートリッジ、その他

• 英文タイトル:Global Microfluidic Immunoassay System Market Insights, Forecast to 2028

Global Microfluidic Immunoassay System Market Insights, Forecast to 2028「世界のマイクロ流体イムノアッセイ システム市場(~2028年):マイクロ流体解析装置、マイクロ流体カートリッジ、その他」(市場規模、市場予測)調査レポートです。• レポートコード:MRC2Q12-17910
• 出版社/出版日:QYResearch / 2022年12月
• レポート形態:英文、PDF、110ページ
• 納品方法:Eメール(納期:3営業日)
• 産業分類:医療機器&消耗品
• 販売価格(消費税別)
  Single User¥725,200 (USD4,900)▷ お問い合わせ
  Enterprise License¥1,450,400 (USD9,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、マイクロ流体イムノアッセイ システムのグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。
マイクロ流体イムノアッセイ システムのアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。
マイクロ流体イムノアッセイ システムの中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。
マイクロ流体イムノアッセイ システムのヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。

生産面において、本レポートは2017年から2022年までのマイクロ流体イムノアッセイ システムの生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別のマイクロ流体イムノアッセイ システムの売上および2028年までの予測に焦点を当てています。

マイクロ流体イムノアッセイ システムのグローバル主要企業には、Abbott Laboratories、Quidel Corporation、Abaxis、Nanōmix、Koninklijke Philips、Biosurfit SA、Micropoint Bioscience、Siloam Biosciences、NanoEnTek、OPKO Healthなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx%の市場シェアを占めています。

マイクロ流体イムノアッセイ システム市場は、タイプとアプリケーションによって区分されます。世界のマイクロ流体イムノアッセイ システム市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年~2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。

【タイプ別セグメント】
マイクロ流体解析装置、マイクロ流体カートリッジ、その他

【アプリケーション別セグメント】
病院、研究所、その他

【掲載地域】
北米:アメリカ、カナダ
ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋:日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米:メキシコ、ブラジル、アルゼンチン
中東・アフリカ:トルコ、サウジアラビア、UAE

【目次(一部)】

・調査の範囲
- マイクロ流体イムノアッセイ システム製品概要
- タイプ別市場(マイクロ流体解析装置、マイクロ流体カートリッジ、その他)
- アプリケーション別市場(病院、研究所、その他)
- 調査の目的
・エグゼクティブサマリー
- 世界のマイクロ流体イムノアッセイ システム販売量予測2017-2028
- 世界のマイクロ流体イムノアッセイ システム売上予測2017-2028
- マイクロ流体イムノアッセイ システムの地域別販売量
- マイクロ流体イムノアッセイ システムの地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別マイクロ流体イムノアッセイ システム販売量
- 主要メーカー別マイクロ流体イムノアッセイ システム売上
- 主要メーカー別マイクロ流体イムノアッセイ システム価格
- 競争状況の分析
- 企業M&A動向
・タイプ別市場規模(マイクロ流体解析装置、マイクロ流体カートリッジ、その他)
- マイクロ流体イムノアッセイ システムのタイプ別販売量
- マイクロ流体イムノアッセイ システムのタイプ別売上
- マイクロ流体イムノアッセイ システムのタイプ別価格
・アプリケーション別市場規模(病院、研究所、その他)
- マイクロ流体イムノアッセイ システムのアプリケーション別販売量
- マイクロ流体イムノアッセイ システムのアプリケーション別売上
- マイクロ流体イムノアッセイ システムのアプリケーション別価格
・北米市場
- 北米のマイクロ流体イムノアッセイ システム市場規模(タイプ別、アプリケーション別)
- 主要国別のマイクロ流体イムノアッセイ システム市場規模(アメリカ、カナダ)
・ヨーロッパ市場
- ヨーロッパのマイクロ流体イムノアッセイ システム市場規模(タイプ別、アプリケーション別)
- 主要国別のマイクロ流体イムノアッセイ システム市場規模(ドイツ、フランス、イギリス、イタリア、ロシア)
・アジア太平洋市場
- アジア太平洋のマイクロ流体イムノアッセイ システム市場規模(タイプ別、アプリケーション別)
- 主要国別のマイクロ流体イムノアッセイ システム市場規模(日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア)
・中南米市場
- 中南米のマイクロ流体イムノアッセイ システム市場規模(タイプ別、アプリケーション別)
- 主要国別のマイクロ流体イムノアッセイ システム市場規模(メキシコ、ブラジル、アルゼンチン)
・中東・アフリカ市場
- 中東・アフリカのマイクロ流体イムノアッセイ システム市場規模(タイプ別、アプリケーション別)
- 主要国別のマイクロ流体イムノアッセイ システム市場規模(トルコ、サウジアラビア)
・企業情報
Abbott Laboratories、Quidel Corporation、Abaxis、Nanōmix、Koninklijke Philips、Biosurfit SA、Micropoint Bioscience、Siloam Biosciences、NanoEnTek、OPKO Health
・産業チェーン及び販売チャネル分析
- マイクロ流体イムノアッセイ システムの産業チェーン分析
- マイクロ流体イムノアッセイ システムの原材料
- マイクロ流体イムノアッセイ システムの生産プロセス
- マイクロ流体イムノアッセイ システムの販売及びマーケティング
- マイクロ流体イムノアッセイ システムの主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- マイクロ流体イムノアッセイ システムの産業動向
- マイクロ流体イムノアッセイ システムのマーケットドライバー
- マイクロ流体イムノアッセイ システムの課題
- マイクロ流体イムノアッセイ システムの阻害要因
・主な調査結果

Microfluidic immunoassay systems are used for disease diagnostic, environmental monitoring, and food and drug screening.
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Microfluidic Immunoassay System is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Microfluidic Immunoassay System is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Microfluidic Immunoassay System is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Microfluidic Immunoassay System include Abbott Laboratories, Quidel Corporation, Abaxis, Nanōmix, Koninklijke Philips, Biosurfit SA, Micropoint Bioscience, Siloam Biosciences and NanoEnTek, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Microfluidic Immunoassay System manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Microfluidic Immunoassay System market. Further, it explains the major drivers and regional dynamics of the global Microfluidic Immunoassay System market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Abbott Laboratories
Quidel Corporation
Abaxis
Nanōmix
Koninklijke Philips
Biosurfit SA
Micropoint Bioscience
Siloam Biosciences
NanoEnTek
OPKO Health
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.
Microfluidic Immunoassay System Segment by Type
Microfluidic Analyzers
Microfluidic Cartridges
Other
Microfluidic Immunoassay System Segment by Application
Hospital
Laboratory
Other
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Microfluidic Immunoassay System market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Microfluidic Immunoassay System, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Microfluidic Immunoassay System, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Microfluidic Immunoassay System, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Microfluidic Immunoassay System sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Microfluidic Immunoassay System market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Microfluidic Immunoassay System sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Abbott Laboratories, Quidel Corporation, Abaxis, Nanōmix, Koninklijke Philips, Biosurfit SA, Micropoint Bioscience, Siloam Biosciences and NanoEnTek, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Microfluidic Immunoassay System in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Microfluidic Immunoassay System manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country, sales and revenue for each segment.
Chapter 9: Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Microfluidic Immunoassay System sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

レポート目次

1 Study Coverage
1.1 Microfluidic Immunoassay System Product Introduction
1.2 Market by Type
1.2.1 Global Microfluidic Immunoassay System Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Microfluidic Analyzers
1.2.3 Microfluidic Cartridges
1.2.4 Other
1.3 Market by Application
1.3.1 Global Microfluidic Immunoassay System Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Laboratory
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Microfluidic Immunoassay System Sales Estimates and Forecasts 2017-2028
2.2 Global Microfluidic Immunoassay System Revenue Estimates and Forecasts 2017-2028
2.3 Global Microfluidic Immunoassay System Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Microfluidic Immunoassay System Sales by Region
2.4.1 Global Microfluidic Immunoassay System Sales by Region (2017-2022)
2.4.2 Global Sales Microfluidic Immunoassay System by Region (2023-2028)
2.5 Global Microfluidic Immunoassay System Revenue by Region
2.5.1 Global Microfluidic Immunoassay System Revenue by Region (2017-2022)
2.5.2 Global Microfluidic Immunoassay System Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Microfluidic Immunoassay System Sales by Manufacturers
3.1.1 Global Top Microfluidic Immunoassay System Manufacturers by Sales (2017-2022)
3.1.2 Global Microfluidic Immunoassay System Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Microfluidic Immunoassay System in 2021
3.2 Global Microfluidic Immunoassay System Revenue by Manufacturers
3.2.1 Global Microfluidic Immunoassay System Revenue by Manufacturers (2017-2022)
3.2.2 Global Microfluidic Immunoassay System Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Microfluidic Immunoassay System Revenue in 2021
3.3 Global Microfluidic Immunoassay System Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Microfluidic Immunoassay System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Microfluidic Immunoassay System Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Microfluidic Immunoassay System Sales by Type
4.1.1 Global Microfluidic Immunoassay System Historical Sales by Type (2017-2022)
4.1.2 Global Microfluidic Immunoassay System Forecasted Sales by Type (2023-2028)
4.1.3 Global Microfluidic Immunoassay System Sales Market Share by Type (2017-2028)
4.2 Global Microfluidic Immunoassay System Revenue by Type
4.2.1 Global Microfluidic Immunoassay System Historical Revenue by Type (2017-2022)
4.2.2 Global Microfluidic Immunoassay System Forecasted Revenue by Type (2023-2028)
4.2.3 Global Microfluidic Immunoassay System Revenue Market Share by Type (2017-2028)
4.3 Global Microfluidic Immunoassay System Price by Type
4.3.1 Global Microfluidic Immunoassay System Price by Type (2017-2022)
4.3.2 Global Microfluidic Immunoassay System Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Microfluidic Immunoassay System Sales by Application
5.1.1 Global Microfluidic Immunoassay System Historical Sales by Application (2017-2022)
5.1.2 Global Microfluidic Immunoassay System Forecasted Sales by Application (2023-2028)
5.1.3 Global Microfluidic Immunoassay System Sales Market Share by Application (2017-2028)
5.2 Global Microfluidic Immunoassay System Revenue by Application
5.2.1 Global Microfluidic Immunoassay System Historical Revenue by Application (2017-2022)
5.2.2 Global Microfluidic Immunoassay System Forecasted Revenue by Application (2023-2028)
5.2.3 Global Microfluidic Immunoassay System Revenue Market Share by Application (2017-2028)
5.3 Global Microfluidic Immunoassay System Price by Application
5.3.1 Global Microfluidic Immunoassay System Price by Application (2017-2022)
5.3.2 Global Microfluidic Immunoassay System Price Forecast by Application (2023-2028)
6 North America
6.1 North America Microfluidic Immunoassay System Market Size by Type
6.1.1 North America Microfluidic Immunoassay System Sales by Type (2017-2028)
6.1.2 North America Microfluidic Immunoassay System Revenue by Type (2017-2028)
6.2 North America Microfluidic Immunoassay System Market Size by Application
6.2.1 North America Microfluidic Immunoassay System Sales by Application (2017-2028)
6.2.2 North America Microfluidic Immunoassay System Revenue by Application (2017-2028)
6.3 North America Microfluidic Immunoassay System Market Size by Country
6.3.1 North America Microfluidic Immunoassay System Sales by Country (2017-2028)
6.3.2 North America Microfluidic Immunoassay System Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Microfluidic Immunoassay System Market Size by Type
7.1.1 Europe Microfluidic Immunoassay System Sales by Type (2017-2028)
7.1.2 Europe Microfluidic Immunoassay System Revenue by Type (2017-2028)
7.2 Europe Microfluidic Immunoassay System Market Size by Application
7.2.1 Europe Microfluidic Immunoassay System Sales by Application (2017-2028)
7.2.2 Europe Microfluidic Immunoassay System Revenue by Application (2017-2028)
7.3 Europe Microfluidic Immunoassay System Market Size by Country
7.3.1 Europe Microfluidic Immunoassay System Sales by Country (2017-2028)
7.3.2 Europe Microfluidic Immunoassay System Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Microfluidic Immunoassay System Market Size by Type
8.1.1 Asia Pacific Microfluidic Immunoassay System Sales by Type (2017-2028)
8.1.2 Asia Pacific Microfluidic Immunoassay System Revenue by Type (2017-2028)
8.2 Asia Pacific Microfluidic Immunoassay System Market Size by Application
8.2.1 Asia Pacific Microfluidic Immunoassay System Sales by Application (2017-2028)
8.2.2 Asia Pacific Microfluidic Immunoassay System Revenue by Application (2017-2028)
8.3 Asia Pacific Microfluidic Immunoassay System Market Size by Region
8.3.1 Asia Pacific Microfluidic Immunoassay System Sales by Region (2017-2028)
8.3.2 Asia Pacific Microfluidic Immunoassay System Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Microfluidic Immunoassay System Market Size by Type
9.1.1 Latin America Microfluidic Immunoassay System Sales by Type (2017-2028)
9.1.2 Latin America Microfluidic Immunoassay System Revenue by Type (2017-2028)
9.2 Latin America Microfluidic Immunoassay System Market Size by Application
9.2.1 Latin America Microfluidic Immunoassay System Sales by Application (2017-2028)
9.2.2 Latin America Microfluidic Immunoassay System Revenue by Application (2017-2028)
9.3 Latin America Microfluidic Immunoassay System Market Size by Country
9.3.1 Latin America Microfluidic Immunoassay System Sales by Country (2017-2028)
9.3.2 Latin America Microfluidic Immunoassay System Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Microfluidic Immunoassay System Market Size by Type
10.1.1 Middle East and Africa Microfluidic Immunoassay System Sales by Type (2017-2028)
10.1.2 Middle East and Africa Microfluidic Immunoassay System Revenue by Type (2017-2028)
10.2 Middle East and Africa Microfluidic Immunoassay System Market Size by Application
10.2.1 Middle East and Africa Microfluidic Immunoassay System Sales by Application (2017-2028)
10.2.2 Middle East and Africa Microfluidic Immunoassay System Revenue by Application (2017-2028)
10.3 Middle East and Africa Microfluidic Immunoassay System Market Size by Country
10.3.1 Middle East and Africa Microfluidic Immunoassay System Sales by Country (2017-2028)
10.3.2 Middle East and Africa Microfluidic Immunoassay System Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Corporation Information
11.1.2 Abbott Laboratories Overview
11.1.3 Abbott Laboratories Microfluidic Immunoassay System Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Abbott Laboratories Microfluidic Immunoassay System Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Abbott Laboratories Recent Developments
11.2 Quidel Corporation
11.2.1 Quidel Corporation Corporation Information
11.2.2 Quidel Corporation Overview
11.2.3 Quidel Corporation Microfluidic Immunoassay System Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Quidel Corporation Microfluidic Immunoassay System Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Quidel Corporation Recent Developments
11.3 Abaxis
11.3.1 Abaxis Corporation Information
11.3.2 Abaxis Overview
11.3.3 Abaxis Microfluidic Immunoassay System Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Abaxis Microfluidic Immunoassay System Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Abaxis Recent Developments
11.4 Nanōmix
11.4.1 Nanōmix Corporation Information
11.4.2 Nanōmix Overview
11.4.3 Nanōmix Microfluidic Immunoassay System Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Nanōmix Microfluidic Immunoassay System Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Nanōmix Recent Developments
11.5 Koninklijke Philips
11.5.1 Koninklijke Philips Corporation Information
11.5.2 Koninklijke Philips Overview
11.5.3 Koninklijke Philips Microfluidic Immunoassay System Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Koninklijke Philips Microfluidic Immunoassay System Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Koninklijke Philips Recent Developments
11.6 Biosurfit SA
11.6.1 Biosurfit SA Corporation Information
11.6.2 Biosurfit SA Overview
11.6.3 Biosurfit SA Microfluidic Immunoassay System Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Biosurfit SA Microfluidic Immunoassay System Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Biosurfit SA Recent Developments
11.7 Micropoint Bioscience
11.7.1 Micropoint Bioscience Corporation Information
11.7.2 Micropoint Bioscience Overview
11.7.3 Micropoint Bioscience Microfluidic Immunoassay System Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Micropoint Bioscience Microfluidic Immunoassay System Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Micropoint Bioscience Recent Developments
11.8 Siloam Biosciences
11.8.1 Siloam Biosciences Corporation Information
11.8.2 Siloam Biosciences Overview
11.8.3 Siloam Biosciences Microfluidic Immunoassay System Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Siloam Biosciences Microfluidic Immunoassay System Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Siloam Biosciences Recent Developments
11.9 NanoEnTek
11.9.1 NanoEnTek Corporation Information
11.9.2 NanoEnTek Overview
11.9.3 NanoEnTek Microfluidic Immunoassay System Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 NanoEnTek Microfluidic Immunoassay System Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 NanoEnTek Recent Developments
11.10 OPKO Health
11.10.1 OPKO Health Corporation Information
11.10.2 OPKO Health Overview
11.10.3 OPKO Health Microfluidic Immunoassay System Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 OPKO Health Microfluidic Immunoassay System Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 OPKO Health Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Microfluidic Immunoassay System Industry Chain Analysis
12.2 Microfluidic Immunoassay System Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Microfluidic Immunoassay System Production Mode & Process
12.4 Microfluidic Immunoassay System Sales and Marketing
12.4.1 Microfluidic Immunoassay System Sales Channels
12.4.2 Microfluidic Immunoassay System Distributors
12.5 Microfluidic Immunoassay System Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Microfluidic Immunoassay System Industry Trends
13.2 Microfluidic Immunoassay System Market Drivers
13.3 Microfluidic Immunoassay System Market Challenges
13.4 Microfluidic Immunoassay System Market Restraints
14 Key Findings in The Global Microfluidic Immunoassay System Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer